/

Empresas

4M

No verificado

4Moving Biotech

Sobre qué escribimos

BiotecnologíaFarmacéuticaFitnessIndustriaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

08/01/2026

4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics

Fuente

4Moving Biotech

Editor

1.00

0

16/07/2025

Ciencia

Sanidad

Farmacéutica

Fitness

Medicina - Varios

Biotecnología

Salud

Industria

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis

Fuente

4Moving Biotech

Editor

1.00

0

27/03/2025

Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis

Fuente

4Moving Biotech

Editor

1.00

0

02/07/2024

4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth

Fuente

4Moving Biotech

Editor

1.00

0

Seguidores

0

Compatibilidad

0